From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Doctors at the University of Cincinnati Cancer Center are exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.The vaccines are developed from a patient's own ...
(CAMBRIDGE, MASS.) December 05, 2024 – Lung cancer is the leading cause of cancer death worldwide, with various subtypes affecting millions of people each year. Among these, ALK-positive lung cancer ...
At 36 months, the disease-free survival and molecular residual disease event-free rate was 86 vs 36% for patients in the osimertinib and placebo groups. HealthDay News — For patients with resected ...
If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach. In what ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University College London, ...
Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed ...
Samsung Medical Center announced that its researchers have developed a new AI model capable of predicting the recurrence risk of non-small cell lung cancer up to a year in advance. According to the ...
Mark Sorin has received funding from the Fonds de recherche du Québec and Vanier Canada Graduate Scholarships. Logan Walsh has received funding from McGill University's Interdisciplinary Infection and ...
Bioinformatics study on genes related to a high-risk postoperative recurrence of lung adenocarcinoma
In this study, we aimed to screen out genes associated with a high risk of postoperative recurrence of lung adenocarcinoma and investigate the possible mechanisms of the involvement of these genes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback